Skip to main content

Balyasny Asset Management L.P.

Position in VKTX — Viking Therapeutics, Inc.

CIK 1218710 Chicago, IL

Position in VKTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,521,493
+$3,334,011 QoQ
Shares Held
115,906
+217.6% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#72
of 435 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Dec 31, 2025
CallValue
$260,332
CallShares
7,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names. VKTX ranks #86 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VKTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,521,493 115,906
2026-03-31 $1,187,482 36,493
2025-12-31 $260,332 7,400
2025-09-30 $5,450,472 207,400
2025-06-30 $62,839,450 2,371,300
2025-03-31 $70,972,020 2,938,800
2025-03-31 $39,814,366 1,648,628
2025-03-31 $369,495 15,300
2024-12-31 $1,006,000 25,000
2024-12-31 $18,405,776 457,400
2024-12-31 $34,624,467 860,449
2024-09-30 $1,728,363 27,300
2024-09-30 $1,747,356 27,600
2024-06-30 $3,042,774 57,400
2024-06-30 $9,827,099 185,382
2024-03-31 $8,904,790 108,595
2023-12-31 $41,751,963 2,243,523
2023-12-31 $2,326,250 125,000
2023-09-30 $23,489,421 2,121,899
2023-09-30 $11,512,800 1,040,000
2023-06-30 $9,973,494 615,268
2023-03-31 $9,267,505 556,607
2022-12-31 $975,437 103,770
2022-09-30 $7,272,094 2,673,564
2022-06-30 $7,638,128 2,642,951
2020-06-30 $75,056 10,410